Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125448471 | 12544847 | 1 | I | 20160506 | 20160704 | 20160711 | 20160711 | EXP | FR-PFIZER INC-2016329978 | PFIZER | 69.00 | YR | M | Y | 0.00000 | 20160711 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125448471 | 12544847 | 1 | PS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, DAILY | Y | 20702 | 40 | MG | FILM-COATED TABLET | ||||||
| 125448471 | 12544847 | 2 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 75 MG, DAILY | 0 | 75 | MG | |||||||||
| 125448471 | 12544847 | 3 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | 100 MG, DAILY | 0 | 100 | MG | |||||||||
| 125448471 | 12544847 | 4 | C | GLICLAZIDE | GLICLAZIDE | 1 | 160 MG, DAILY | 0 | 160 | MG | |||||||||
| 125448471 | 12544847 | 5 | C | BIPRETERAX /06377001/ | INDAPAMIDEPERINDOPRIL | 1 | 1 DF, DAILY | 0 | 1 | DF | |||||||||
| 125448471 | 12544847 | 6 | C | ERYTHROMYCINE /00020901/ | ERYTHROMYCIN | 1 | 250 MG, 4X/DAY | 0 | 250 | MG | QID | ||||||||
| 125448471 | 12544847 | 7 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | 10 MG, 3X/DAY | 0 | 10 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125448471 | 12544847 | 1 | Hypercholesterolaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125448471 | 12544847 | LT |
| 125448471 | 12544847 | OT |
| 125448471 | 12544847 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125448471 | 12544847 | Blood creatine phosphokinase increased | |
| 125448471 | 12544847 | Hepatic encephalopathy | |
| 125448471 | 12544847 | Pleural effusion | |
| 125448471 | 12544847 | Pulmonary congestion | |
| 125448471 | 12544847 | Rhabdomyolysis | |
| 125448471 | 12544847 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125448471 | 12544847 | 1 | 20160602 | 0 | ||
| 125448471 | 12544847 | 2 | 20160602 | 0 | ||
| 125448471 | 12544847 | 3 | 20160602 | 0 | ||
| 125448471 | 12544847 | 4 | 20160602 | 0 | ||
| 125448471 | 12544847 | 5 | 20160602 | 0 | ||
| 125448471 | 12544847 | 6 | 20160526 | 0 | ||
| 125448471 | 12544847 | 7 | 20160526 | 0 |